Abstract
BackgroundAtrioventricular nodal ablation (AVNA) is indicated in drug-refractory atrial fibrillation (AF)[1], and has been shown to improve cardiac resynchronization therapy (CRT) efficacy in this cohort[2]. There is concern over the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
